Hegde Priti 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Hegde Priti
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-15+16,800→ 16,800 totalExercise: $0.97Exp: 2032-12-14→ Common Stock (16,800 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.